These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

490 related items for PubMed ID: 9710362

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Long-term treatment of bromocriptine-intolerant prolactinoma patients with CV 205-502.
    Glaser B, Nesher Y, Barziliai S.
    J Reprod Med; 1994 Jun; 39(6):449-54. PubMed ID: 7932398
    [Abstract] [Full Text] [Related]

  • 4. Long-term outcome of patients with macroprolactinomas initially treated with dopamine agonists.
    Kars M, Pereira AM, Smit JW, Romijn JA.
    Eur J Intern Med; 2009 Jul; 20(4):387-93. PubMed ID: 19524180
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Surgical outcomes in hyporesponsive prolactinomas: analysis of patients with resistance or intolerance to dopamine agonists.
    Hamilton DK, Vance ML, Boulos PT, Laws ER.
    Pituitary; 2005 Jul; 8(1):53-60. PubMed ID: 16411069
    [Abstract] [Full Text] [Related]

  • 9. [Bromocriptine treatment of invasive giant prolactinomas prior to comprehensive treatments: results of a long-term follow up].
    Zhang HW, Yu CJ, Sun W, Yang J, Yan CX, Cun EH.
    Zhonghua Wai Ke Za Zhi; 2006 Nov 15; 44(22):1555-7. PubMed ID: 17359664
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. 10-year follow-up study comparing primary medical vs. surgical therapy in women with prolactinomas.
    Andereggen L, Frey J, Andres RH, El-Koussy M, Beck J, Seiler RW, Christ E.
    Endocrine; 2017 Jan 15; 55(1):223-230. PubMed ID: 27688009
    [Abstract] [Full Text] [Related]

  • 14. Outcomes of transsphenoidal surgery in prolactinomas: improvement of hormonal control in dopamine agonist-resistant patients.
    Primeau V, Raftopoulos C, Maiter D.
    Eur J Endocrinol; 2012 May 15; 166(5):779-86. PubMed ID: 22301915
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Results of treatment for male prolactinomas].
    Iwai Y, Yamanaka K, Ishiguro T, Morikawa T, Matsuzaka Y, Komiyama M, Yasui T.
    No Shinkei Geka; 2002 Dec 15; 30(12):1285-92. PubMed ID: 12491580
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Potential for long-term remission of microprolactinoma after withdrawal of dopamine-agonist therapy.
    Bronstein MD.
    Nat Clin Pract Endocrinol Metab; 2006 Mar 15; 2(3):130-1. PubMed ID: 16932269
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.